- Home
- CSV vs GHRS Comparison
CSV vs GHRS Comparison
Compare CSV & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSV
- GHRS
- Stock Information
- Founded
- CSV 1991
- GHRS 2018
- Country
- CSV United States
- GHRS Ireland
- Employees
- CSV N/A
- GHRS N/A
- Industry
- CSV Other Consumer Services
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- CSV Consumer Discretionary
- GHRS Health Care
- Exchange
- CSV Nasdaq
- GHRS Nasdaq
- Market Cap
- CSV 670.2M
- GHRS 774.1M
- IPO Year
- CSV 1996
- GHRS 2021
- Fundamental
- Price
- CSV $44.17
- GHRS $13.77
- Analyst Decision
- CSV Strong Buy
- GHRS Strong Buy
- Analyst Count
- CSV 4
- GHRS 9
- Target Price
- CSV $59.00
- GHRS $29.33
- AVG Volume (30 Days)
- CSV 77.3K
- GHRS 293.7K
- Earning Date
- CSV 11-05-2025
- GHRS 11-13-2025
- Dividend Yield
- CSV 1.00%
- GHRS N/A
- EPS Growth
- CSV 75.49
- GHRS N/A
- EPS
- CSV 3.32
- GHRS N/A
- Revenue
- CSV $407,603,000.00
- GHRS N/A
- Revenue This Year
- CSV $3.97
- GHRS N/A
- Revenue Next Year
- CSV $3.40
- GHRS N/A
- P/E Ratio
- CSV $13.31
- GHRS N/A
- Revenue Growth
- CSV 3.15
- GHRS N/A
- 52 Week Low
- CSV $32.31
- GHRS $6.72
- 52 Week High
- CSV $49.41
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- CSV 44.14
- GHRS 52.03
- Support Level
- CSV $44.76
- GHRS $12.40
- Resistance Level
- CSV $45.89
- GHRS $14.54
- Average True Range (ATR)
- CSV 0.91
- GHRS 0.88
- MACD
- CSV -0.07
- GHRS 0.06
- Stochastic Oscillator
- CSV 16.63
- GHRS 57.24
About CSV Carriage Services Inc.
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.